Research To Practice | Oncology Videos: Acute Myeloid Leukemia and Myelodysplastic Syndromes | Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes – A Review of the 2022 ASCO Annual Meeting and EHA Congress

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes – A Review of the 2022 ASCO Annual Meeting and EHA Congress

Jul 27, 2022

Featuring perspectives from Dr Richard Stone, including the following topics:

Introduction: RATIFY trial in perspective (0:00)
Treatment with FLT3 inhibitors (7:00)
Anti-CD47 antibody: Magrolimab (23:04)
Anti-TIM-3 antibody: Sabatolimab (31:23)
CAR T-cell therapy for acute myeloid leukemia (34:53)
Targeted therapy with IDH inhibitors (37:31)
New myelodysplastic syndromes classification system (41:20)
Hypomethylating agents/venetoclax (45:11)
CPX-351 (49:14)
Other key data sets (50:59)